论文部分内容阅读
从1934年挪威奈科明制药有限公司生产第一只造影剂UROTRAST开始,到90年代一批又一批用于各种诊断仪器的新型造影剂上市,奈科明制药有限公司已经历了60多年造影剂发展的历史。由于强烈的产品开发意识和独特的市场策略,该公司在激烈的国际市场竞争中始终保持着领先地位。 1 不惜巨额资金开发新产品 挪威奈科明制药公司成立于1874年,原来是一家靠进口原料配制药品进行销售的制药公司。1929年一名德国科学家发明了用一种含碘的化学物质通过X射线对人体进行造影以后,奈科明公司看到了了生产造影剂在放射领域
From the first URRATAST contrast agent produced by Nycomed Pharmaceuticals in Norway in 1934, to the new batch of new contrast agents used in various diagnostic instruments in the 1990s, Nycomed Pharmaceuticals Co., Ltd. has gone through more than 60 years. The history of contrast agent development. Due to strong product development awareness and unique marketing strategies, the company has always maintained a leading position in the fierce international market competition. 1 Development of new products at huge amounts of money Founded in 1874, the Norwegian company Nycomed Pharmaceuticals was originally a pharmaceutical company that relies on imported raw materials for the manufacture of pharmaceuticals. After a German scientist invented an X-ray image of the human body with an iodine-containing chemical in 1929, Nycomed saw the production of contrast agents in the field of radiation.